US Patent Office Updates Appeal Procedures In Wake Of Arthrex Decision
Executive Summary
The interim process allows review of patent board verdicts by the director of the patent office either at the director’s initiative, or upon request of an involved party.
You may also be interested in...
Attorney: Expect PTO Director To Use ‘Discretion’ In New Patent Appeal Authority
The US Supreme Court found that the role of administrative judges in patent review was unconstitutional but could be fixed by giving the PTO’s director more oversight, reinforcing the staying power of the patent appeals process.
For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component
Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.
FDA Plans Meeting On Pulse Oximeter Accuracy
US regulators plan to hold a public meeting later this year to address concerns the devices are less accurate for people with darker skin tones.